The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
APPIAN CORP | CL A | 03782L101 | 1,763 | 70,000 | SH | SOLE | 0 | 0 | 70,000 | ||
COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 2,190 | 85,714 | SH | SOLE | 0 | 0 | 85,714 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 1,093 | 114,286 | SH | SOLE | 0 | 0 | 114,286 | ||
JBG SMITH PPTYS | COM | 46590V100 | 59,323 | 1,759,817 | SH | SOLE | 0 | 0 | 1,759,817 | ||
OKTA INC | CL A | 679295105 | 1,993 | 50,000 | SH | SOLE | 0 | 0 | 50,000 | ||
STAR GROUP L P | UNIT LTD PARTNR | 85512C105 | 561 | 60,000 | SH | SOLE | 0 | 0 | 60,000 |